PL3600315T3 - Nowe terapeutyczne zastosowanie ligandów h3 - Google Patents
Nowe terapeutyczne zastosowanie ligandów h3Info
- Publication number
- PL3600315T3 PL3600315T3 PL18714194.0T PL18714194T PL3600315T3 PL 3600315 T3 PL3600315 T3 PL 3600315T3 PL 18714194 T PL18714194 T PL 18714194T PL 3600315 T3 PL3600315 T3 PL 3600315T3
- Authority
- PL
- Poland
- Prior art keywords
- ligands
- therapeutical use
- new therapeutical
- new
- therapeutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17305309.1A EP3378477A1 (en) | 2017-03-21 | 2017-03-21 | New therapeutical use of h3-ligands |
| PCT/EP2018/057215 WO2018172432A1 (en) | 2017-03-21 | 2018-03-21 | New therapeutical use of h3-ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3600315T3 true PL3600315T3 (pl) | 2024-03-18 |
Family
ID=58464477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18714194.0T PL3600315T3 (pl) | 2017-03-21 | 2018-03-21 | Nowe terapeutyczne zastosowanie ligandów h3 |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US11179329B2 (pl) |
| EP (2) | EP3378477A1 (pl) |
| JP (2) | JP7634987B2 (pl) |
| KR (1) | KR20190125354A (pl) |
| CN (1) | CN110891570A (pl) |
| AU (1) | AU2018238411B2 (pl) |
| BR (1) | BR112019019633A2 (pl) |
| CA (1) | CA3056710A1 (pl) |
| DK (1) | DK3600315T3 (pl) |
| ES (1) | ES2971063T3 (pl) |
| FI (1) | FI3600315T3 (pl) |
| HR (1) | HRP20231568T1 (pl) |
| HU (1) | HUE064403T2 (pl) |
| IL (1) | IL269424B2 (pl) |
| LT (1) | LT3600315T (pl) |
| MA (1) | MA48983A (pl) |
| MX (1) | MX388589B (pl) |
| NZ (1) | NZ757456A (pl) |
| PL (1) | PL3600315T3 (pl) |
| PT (1) | PT3600315T (pl) |
| RS (1) | RS64910B1 (pl) |
| RU (1) | RU2757996C2 (pl) |
| SI (1) | SI3600315T1 (pl) |
| SM (1) | SMT202300460T1 (pl) |
| WO (1) | WO2018172432A1 (pl) |
| ZA (1) | ZA201906238B (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3378858A1 (en) * | 2017-03-21 | 2018-09-26 | Bioprojet | Tetrahydrate of h3 ligand, its process of preparation and pharmaceutical compositions comprising the same |
| DK3598975T3 (da) | 2018-07-27 | 2020-11-02 | Bioprojet Soc Civ | Hidtil ukendte kombinationer af en H3-antagonist og en noradrenalin-genoptagelseshæmmer, og de terapeutiske anvendelser deraf |
| WO2020092604A1 (en) * | 2018-10-30 | 2020-05-07 | Concert Pharmaceuticals, Inc. | Deuterated pitolisant |
| SG11202113211PA (en) * | 2019-06-03 | 2021-12-30 | Biotheryx Inc | Non-hygroscopic crystalline salts of a pyrazole compound, and pharmaceutical compositions and use thereof |
| CN120698949A (zh) * | 2022-02-22 | 2025-09-26 | 上海云晟研新生物科技有限公司 | 卡利拉嗪药用盐及其晶型、药物组合物、制备方法和用途 |
| TW202535386A (zh) * | 2023-10-16 | 2025-09-16 | 法商拜爾普羅傑特醫藥有限公司 | 腸溶包衣必托里賽(pitolisant)調配物及使用方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2579596B1 (fr) * | 1985-03-26 | 1987-11-20 | Inst Nat Sante Rech Med | (imidazolyl-4) piperidines, leur preparation et leur application en therapeutique |
| FR2660862B1 (fr) * | 1990-04-13 | 1994-09-23 | Bioprojet Soc Civ | Application therapeutique de derives de l'histamine, nouveau derive de l'histamine et utilisation de ces derives pour la preparation de medicaments. |
| EP0982300A3 (en) * | 1998-07-29 | 2000-03-08 | Societe Civile Bioprojet | Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications |
| CA2481532A1 (en) | 2002-04-12 | 2003-10-23 | Pfizer Inc. | Imidazole compounds as anti-inflammatory and analgesic agents |
| ATE539074T1 (de) | 2003-12-11 | 2012-01-15 | Abbott Lab | Die hiv-protease hemmende verbindungen |
| EP1717235A3 (en) | 2005-04-29 | 2007-02-28 | Bioprojet | Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands |
| US20090170869A1 (en) * | 2007-09-06 | 2009-07-02 | Desmond John Best | Piperazine derivative having affinity for the histamine h3 receptor |
| CN102131505A (zh) | 2008-06-20 | 2011-07-20 | 阿斯利康(瑞典)有限公司 | 用于调节β2-肾上腺素受体活性的包含4-羟基-2-氧代-2,3-二氢-1,3-苯并噻唑-7-基化合物的药物组合物 |
| AU2010360038B2 (en) * | 2010-09-02 | 2014-05-15 | Suven Life Sciences Limited | Heterocyclyl compounds as Histamine H3 receptor ligands |
| US9212180B2 (en) * | 2013-06-12 | 2015-12-15 | The Regents Of The University Of Michigan | Menin-MLL inhibitors and methods of use thereof |
| EP3378858A1 (en) * | 2017-03-21 | 2018-09-26 | Bioprojet | Tetrahydrate of h3 ligand, its process of preparation and pharmaceutical compositions comprising the same |
-
2017
- 2017-03-21 EP EP17305309.1A patent/EP3378477A1/en not_active Withdrawn
-
2018
- 2018-03-21 RU RU2019129447A patent/RU2757996C2/ru active
- 2018-03-21 HU HUE18714194A patent/HUE064403T2/hu unknown
- 2018-03-21 WO PCT/EP2018/057215 patent/WO2018172432A1/en not_active Ceased
- 2018-03-21 DK DK18714194.0T patent/DK3600315T3/da active
- 2018-03-21 CA CA3056710A patent/CA3056710A1/en active Pending
- 2018-03-21 ES ES18714194T patent/ES2971063T3/es active Active
- 2018-03-21 BR BR112019019633A patent/BR112019019633A2/pt not_active Application Discontinuation
- 2018-03-21 EP EP18714194.0A patent/EP3600315B1/en active Active
- 2018-03-21 US US16/496,126 patent/US11179329B2/en active Active
- 2018-03-21 SI SI201831033T patent/SI3600315T1/sl unknown
- 2018-03-21 MX MX2019011183A patent/MX388589B/es unknown
- 2018-03-21 MA MA048983A patent/MA48983A/fr unknown
- 2018-03-21 KR KR1020197027608A patent/KR20190125354A/ko not_active Ceased
- 2018-03-21 FI FIEP18714194.0T patent/FI3600315T3/fi active
- 2018-03-21 HR HRP20231568TT patent/HRP20231568T1/hr unknown
- 2018-03-21 AU AU2018238411A patent/AU2018238411B2/en active Active
- 2018-03-21 PT PT187141940T patent/PT3600315T/pt unknown
- 2018-03-21 PL PL18714194.0T patent/PL3600315T3/pl unknown
- 2018-03-21 LT LTEPPCT/EP2018/057215T patent/LT3600315T/lt unknown
- 2018-03-21 RS RS20231162A patent/RS64910B1/sr unknown
- 2018-03-21 NZ NZ757456A patent/NZ757456A/en unknown
- 2018-03-21 SM SM20230460T patent/SMT202300460T1/it unknown
- 2018-03-21 CN CN201880028223.5A patent/CN110891570A/zh active Pending
- 2018-03-21 JP JP2020501592A patent/JP7634987B2/ja active Active
-
2019
- 2019-09-18 IL IL269424A patent/IL269424B2/en unknown
- 2019-09-20 ZA ZA2019/06238A patent/ZA201906238B/en unknown
-
2022
- 2022-10-27 JP JP2022172621A patent/JP2023001210A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202006746B (en) | Methods of treatment | |
| ZA201905677B (en) | Glycan-interacting compounds and methods of use | |
| GB201709435D0 (en) | Medical devices | |
| GB201804514D0 (en) | Treatment of pyroptosis | |
| ZA201906238B (en) | New therapeutical use of h3-ligands | |
| IL265955A (en) | Therapeutic compounds and methods of using them | |
| PT3661491T (pt) | 3-metilmetcatinona para uso no tratamento de um indivíduo sob uma intervenção psicoterapêutica | |
| IL285882A (en) | Medicinal uses for l–4–chlorokynurenine | |
| GB201715194D0 (en) | Compounds and their therapeutic use | |
| GB201608797D0 (en) | Therapeutic use | |
| ZA201802134B (en) | Therapeutic compounds and methods of use thereof | |
| GB201804515D0 (en) | Treatment of necroptosis | |
| GB201700526D0 (en) | Therapeutic use | |
| SG11202005850VA (en) | Methods of treatment of hypertrigl yceridemia | |
| ZA202105399B (en) | Use of spiropidion | |
| GB201705686D0 (en) | Novel compounds and therapeutic uses thereof | |
| GB2568495B (en) | Methods of coating medical devices | |
| GB201707500D0 (en) | New therapy | |
| SG11202105136WA (en) | Application of chidamide | |
| GB201705684D0 (en) | Novel compounds and therapeutic uses thereof | |
| GB201810835D0 (en) | Methods of use | |
| GB2558788B (en) | New therapeutic uses | |
| GB201721386D0 (en) | Chrondogy of time-wave | |
| GB201707076D0 (en) | Novel compounds and therapeutic uses thereof | |
| GB201705685D0 (en) | Novel compounds and therapeutic uses thereof |